Page 3 - Contrafect Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contrafect corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contrafect Corporation Today - Breaking & Trending Today

ContraFect (NASDAQ:CFRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report report published on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance CFRX opened at $0.07 on Friday. The company has a market cap of $749,000.00, a PE ratio of 0.00 and a […] ....

United States , Dimensional Fund Advisors , Vanguard Group Inc , Envestnet Asset Management Inc , Contrafect Corporation , Contrafect Company Profile , Goldman Sachs Group Inc , Free Report , Get Free Report , Sachs Group , Asset Management , Street Corp , Fund Advisors , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,

ContraFect Co. (NASDAQ:CFRX) Short Interest Down 48.6% in October

ContraFect Co. (NASDAQ:CFRX – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 59,600 shares, a decline of 48.6% from the October 15th total of 116,000 shares. Based on an average daily trading volume, of 217,000 shares, […] ....

United States , Contrafect Company Profile , Vanguard Group Inc , Armistice Capital , Contrafect Corporation , Contrafect Co , Virtu Financial , Goldman Sachs Group Inc , Renaissance Technologies , Get Free Report , Sachs Group , Fect Corporation , Contrafect Daily , Nasdaq Cfrx ,

ContraFect (NASDAQ:CFRX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Trading Down 8.2 % NASDAQ:CFRX opened at $0.27 on Friday. The stock has a market capitalization of $2.90 million, a price-to-earnings ratio of -0.01 […] ....

United States , Virtu Financial , Contrafect Company Profile , Renaissance Technologies , Dimensional Fund Advisors , Armistice Capital , Contrafect Corporation , Free Report , Fect Trading Down , Get Free Report , Sigma Investments , Fund Advisors , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,